title: [The neoadjuvant treatment of gastrointestinal tumors: time for rethinking?].
authors.affiliation: II. Medizinische Klinik des Klinikums rechts der Isar Technische Universität München, München. Matthias.Ebert@lrz.tum.de
authors.forename: M P
authors.initials: MP
authors.lastname: Ebert
authors.forename: R M
authors.initials: RM
authors.lastname: Schmid
mesh_terms: D000230:Adenocarcinoma / Q000628:therapy; D001661:Biliary Tract Neoplasms / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D004067:Digestive System Neoplasms / Q000628:therapy*; D004938:Esophageal Neoplasms / Q000628:therapy; D005770:Gastrointestinal Neoplasms / Q000628:therapy*; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy; D020360:Neoadjuvant Therapy / Q000379:methods* / Q000639:trends; D010190:Pancreatic Neoplasms / Q000628:therapy; D018714:Radiotherapy, Adjuvant; D012004:Rectal Neoplasms / Q000628:therapy; D013274:Stomach Neoplasms / Q000628:therapy